AP1M2缺陷导致伴结肠炎的新型自身炎症性疾病
本研究首次发现AP1M2双等位基因功能缺失变异可导致伴结肠炎的自身炎症性疾病,并通过Ap1m2缺陷小鼠和DLD-1细胞阐明其发病机制。机制上,AP1M2缺陷导致肠上皮细胞TNFR1信号下游蛋白积累,增强NF-κB活化及趋化因子过度产生,而Tnfr1敲除可挽救Ap1m2缺陷诱导的胃肠道炎症。
要点
- AP1M2双等位基因功能缺失变异是伴结肠炎自身炎症性疾病的新病因。
- AP1M2缺陷通过积累TNFR1信号下游蛋白增强NF-κB活化和趋化因子产生。
- Tnfr1敲除可挽救Ap1m2缺陷诱导的胃肠道炎症。
核心结论
- AP1M2缺陷是伴结肠炎的新型自身炎症性疾病的病因,AP-1在抑制NF-κB活化和趋化因子产生中起关键作用。
研究设计与样本
- 研究采集患者血液和血清样本分别用于遗传诊断和炎性细胞因子检测。
- 使用C57BL/6背景的Ap1m2缺陷小鼠和DLD-1细胞剖析Ap1m2在血清和肠道中的功能。
- 对Ap1m2-/-和Ap1m2-/-::Tnfr1-/-小鼠样本进行Stereo-seq以探究Tnfr1信号的调控作用。
- 采用超分辨成像和网格蛋白包被囊泡富集探究AP1M2抑制NF-κB活化和趋化因子产生的分子机制。
主要发现
- Ap1m2-/-小鼠血清趋化因子产生升高并自发发生肠道炎症,表型模拟携带AP1M2变异的患者。
- 肠上皮特异性AP1M2表达缺陷导致TNFR1信号下游蛋白RIPK1、TBK1、IKKα/β和NEMO积累,增强NF-κB活化及趋化因子过度产生。
- Tnfr1敲除通过抑制NF-κB活化和趋化因子产生挽救Ap1m2缺陷诱导的胃肠道炎症。
临床怎么用
- 对伴结肠炎的自身炎症性疾病患者,可考虑评估AP1M2双等位基因功能缺失变异。
- AP1M2缺陷相关炎症机制涉及TNFR1信号,Tnfr1敲除在 mice 中可挽救肠道炎症,提示TNFR1通路为潜在干预靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study was the first to identify the biallelic loss-of-function variant in AP1M2 as the cause of autoinflammatory disease with colitis and aimed to elucidate the pathogenesis of AP1M2 deficiency in mice and humans. METHODS: We collected a blood sample and serum sample from a patient for genetic diagnosis and determination of inflammatory cytokines, respectively. Ap1m2-deficient mice on the C57BL/6 background and DLD-1 cells were used to dissect the functional role of Ap1m2 in serum and intestines. Stereo-seq was performed on Ap1m2-/- and Ap1m2-/-::Tnfr1-/- mouse samples to investigate the regulatory role of Tnfr1 signaling in the pathogenesis of Ap1m2 deficiency-caused intestinal inflammation. Superrevolution imaging and clathrin-coated vesicle enrichment were used to explore the molecular mechanism by which AP1M2 suppresses NF-κB activation and chemokine production. RESULTS: Ap1m2-/- mice exhibited elevated chemokine production in serum and spontaneously developed intestinal inflammation, which phenocopies the patient with the AP1M2 variant. Mechanistically, the deficiency of intestinal epithelial specific AP1M2 expression resulted in accumulation of TNFR1-signaling downstream proteins, including RIPK1, TBK1, IKKα/β, and NEMO, leading to enhanced NF-κB activation and subsequent chemokine overproduction. Tnfr1 knockout rescued gastrointestinal inflammation induced by Ap1m2 deficiency through suppressing NF-κB activation and chemokine production. CONCLUSION: This study identifies the deficiency of AP1M2 as the cause of a new autoinflammatory disease with colitis and highlights the critical function of AP-1 in suppressing NF-κB activation and chemokine production.
引用
- Jin T, Dai J, Liu C, et al. Deficiency of AP1M2 Causes a New Autoinflammatory Disease With Colitis. Arthritis Rheumatol. 2026. PMID: 41451456. doi:10.1002/art.70038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。